<DOC>
	<DOC>NCT00837720</DOC>
	<brief_summary>This open label, non-interventional study is to show the efficacy of antihypertensive treatment with Atacand in hypertensive patients. Efficacy is to be evaluated based on the difference in systolic and diastolic blood pressure at baseline and at both follow-up visits.</brief_summary>
	<brief_title>Evaluation of Atacand® (Candesartan) in Daily Medical Practice</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<criteria>a patient with arterial hypertension who has been prescribed Atacand according to physician's judgement, irrespective of the inclusion in the study hypersensitivity to candesartan or any other ingredient of Atacand liver function impairment and/or cholestasis severe renal insufficiency woman of childbearing potential and not using appropriate contraceptive measures, pregnancy or lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>hypertension</keyword>
	<keyword>blood pressure</keyword>
	<keyword>Atacand®</keyword>
	<keyword>candesartan</keyword>
</DOC>